BLOOD COUNT ABNORMAL side effect
What is BLOOD COUNT ABNORMAL ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
BLOOD COUNT ABNORMAL and Recently Reported Side Effects
BLOOD COUNT ABNORMAL and 15 most Active Side Effect polls
BLOOD COUNT ABNORMAL and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with BLOOD COUNT ABNORMAL
ACTIQ ALEVE ALIMTA ASPIRIN AVANDIA AVONEX BETASERON BYETTA CELEBREX CHANTIX CLOZARIL CRESTOR CYCLOPHOSPHAMIDE CYTARABINE DACOGEN DECADRON DIGITEK DIGOXIN DILANTIN DURAGESIC ELAPRASE ENBREL EXJADE FENTANYL FLUTAMIDE FORTEO FOSAMAX FUNGUARD GADOLINIUM GEMZAR GLEEVEC HALOPERIDOL HEPARIN HUMIRA INFERGEN INOMAX INTERFERON KEPPRA LETAIRIS LEVAQUIN LIORESAL LIPITOR LYSODREN MIRTAZAPINE NEUPOGEN NEXAVAR NITROFURANTOIN ORTHO PLAVIX PROCRIT REBETOL REBIF REMICADE REVLIMID RIBASPHERE ROGAINE SEROQUEL SUTENT TACROLIMUS TARCEVA TEMODAL TEMOZOLOMIDE TRIAMINIC TYSABRI VALPROIC VIANI ZEVALIN ZOLADEX ZOMETA ZYPREXAAvonex Side Effects Report #5650085-X
Consumer or non-health professional from UNITED STATES reported AVONEX problem on Feb 20, 2008. Female patient, 54 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, haemorrhoids, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.
Tysabri Side Effects Report #5650499-8
TYSABRI problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 04, 2008. Female patient, weighting 165.0 lb, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, depression, gingival disorder, immune system disorder, leprosy, lymphadenopathy, malaise, pruritus, rash, . TYSABRI dosage: 300MG ONCE A MONTH IV. Patient recovered.
Decadron Side Effects Report #5651894-3
Physician from JAPAN reported DECADRON problem on Feb 27, 2008. Male patient, 63 years of age, was diagnosed with multiple myeloma and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, multiple myeloma, nerve injury, . DECADRON dosage: unknown. During the same period patient was treated with THALIDOMIDE, ADRIACIN, CYMERIN, FILDESIN, ALKERAN, PREDONINE. Patient recovered.
Tarceva Side Effects Report #5651917-1
TARCEVA problem was reported by a Health Professional from UNITED STATES on Feb 19, 2008. Male patient was diagnosed with pancreatic carcinoma and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, chest pain, . TARCEVA dosage: 100 MG QD ORAL. Patient was hospitalized. Patient recovered.
Decadron Side Effects Report #5661825-8
Physician from JAPAN reported DECADRON problem on Mar 04, 2008. Male patient, 63 years of age, was diagnosed with multiple myeloma and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, multiple myeloma, nerve injury, . DECADRON dosage: unknown. During the same period patient was treated with THALIDOMIDE, ADRIACIN, CYMERIN, FILDESIN, ALKERAN, PREDONINE. Patient recovered.
Revlimid Side Effects Report #5662857-6
REVLIMID problem was reported by a Physician from UNITED STATES on Mar 03, 2008. Female patient, 60 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, . REVLIMID dosage: QD, ORAL; 15 MG, 14 DAYS ON, 7 DAYS OFF, ORAL. During the same period patient was treated with VELCADE, DEXAMETHASONE. Patient died on 01/12/2008.
Decadron Side Effects Report #5663554-3
Physician from JAPAN reported DECADRON problem on Mar 04, 2008. Male patient, 63 years of age, was diagnosed with multiple myeloma and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, multiple myeloma, nerve injury, . DECADRON dosage: unknown. During the same period patient was treated with THALIDOMIDE, ADRIACIN, CYMERIN, FILDESIN, ALKERAN, PREDONINE. Patient recovered.
Gemzar Side Effects Report #5670436-X
GEMZAR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 04, 2008. Female patient, 86 years of age, was diagnosed with pancreatic carcinoma and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, pulmonary embolism, pulmonary toxicity, . GEMZAR dosage: 1600 MG, OTHER. Patient died on 02/01/2008.
Letairis Side Effects Report #5676263-1
Pharmacist from UNITED STATES reported LETAIRIS problem on Mar 07, 2008. Female patient, weighting 150.1 lb, was diagnosed with pulmonary hypertension and was treated with LETAIRIS. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, dyspnoea, haemoptysis, nasal congestion, palpitations, . LETAIRIS dosage: unknown. During the same period patient was treated with CELLCEPT, COZAAR, XALATAN, LASIX, AMARYL, FOLIC ACID, CARDIZEM CD. Patient was hospitalized. Patient recovered.
Ribasphere Side Effects Report #5679053-9
RIBASPHERE problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 07, 2008. Female patient was diagnosed with hepatitis c virus and was treated with RIBASPHERE. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, platelet count decreased, pleurisy, pulmonary oedema, staphylococcal infection, . RIBASPHERE dosage: (1000 MG ORAL). During the same period patient was treated with PEGASYS. Patient was hospitalized. Patient recovered.
Avonex Side Effects Report #5679796-7
Physician from UNITED STATES reported AVONEX problem on Mar 14, 2008. Female patient, 54 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, haemorrhoids, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.
Cyclophosphamide Side Effects Report #5680188-5
CYCLOPHOSPHAMIDE problem was reported by a Health Professional from UNITED STATES on Mar 19, 2008. Female patient, 48 years of age, was diagnosed with breast cancer and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, oedema peripheral, pain, rash, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with PLATINOL, TAXOTERE, GEMZAR, NAVELBINE, HERCEPTIN, NEUPOGEN. Patient recovered.
Gemzar Side Effects Report #5680231-3
Consumer or non-health professional from UNITED STATES reported GEMZAR problem on Mar 14, 2008. Female patient, 86 years of age, was diagnosed with pancreatic carcinoma and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, pulmonary embolism, pulmonary toxicity, . GEMZAR dosage: 1600 MG, OTHER. Patient died on 02/01/2008.
Revlimid Side Effects Report #5680909-1
REVLIMID problem was reported by a Physician from UNITED STATES on Mar 19, 2008. Male patient, 77 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, pneumonia, white blood cell count decreased, . REVLIMID dosage: 25 MG, 1 IN 1 D; ORAL. Patient died on 12/01/2007.
Gemzar Side Effects Report #5618831-9
Consumer or non-health professional from UNITED STATES reported GEMZAR problem on Jan 28, 2008. Female patient was diagnosed with ovarian cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, blood glucose abnormal, dehydration, nasal congestion, nausea, pain, vomiting, . GEMZAR dosage: unknown. During the same period patient was treated with CISPLATIN, DEXAMETHASONE. Patient was hospitalized. Patient recovered.
Temozolomide Side Effects Report #5625704-4
TEMOZOLOMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 07, 2008. Male patient, weighting 136.0 lb, was diagnosed with acute myeloid leukaemia and was treated with TEMOZOLOMIDE. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, febrile neutropenia, . TEMOZOLOMIDE dosage: 350MG QD PO. During the same period patient was treated with DILTIAZEM, OMEPRAZOLE, SENNA, DULCOLAX, MILK OF MAGNESIA, ALLOPURINOL, KYTRIL. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5630367-8
Consumer or non-health professional from UNITED STATES reported REVLIMID problem on Feb 05, 2008. Male patient, 77 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, pneumonia, . REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient died.
Revlimid Side Effects Report #5631340-6
REVLIMID problem was reported by a Physician from UNITED STATES on Feb 05, 2008. Male patient, 77 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, disease progression, multiple myeloma, neuropathy peripheral, . REVLIMID dosage: 25 MG, X21 DAYS EVERY 28 DAYS, ORAL; 5 MG, 1 IN 1 D, ORAL. Patient died on 10/21/2007.
Revlimid Side Effects Report #5637812-2
Physician from UNITED STATES reported REVLIMID problem on Feb 14, 2008. Male patient, 77 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, disease progression, infection, myelodysplastic syndrome, rash pruritic, sepsis, . REVLIMID dosage: 5 MG, ORAL. Patient died on 01/25/2008.
Revlimid Side Effects Report #5637814-6
REVLIMID problem was reported by a Health Professional from UNITED STATES on Feb 11, 2008. Male patient, 76 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, cerebrovascular accident, fall, hypoaesthesia, ill-defined disorder, loss of control of legs, movement disorder, sensation of heaviness, transient ischaemic attack, . REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL; 5 MG, 1 IN 1 D, ORAL. During the same period patient was treated with PROCRIT, NEUPOGEN, EPOGEN. Patient was hospitalized. Patient died on 09/19/2006.
Revlimid Side Effects Report #5639399-7
Health Professional from UNITED STATES reported REVLIMID problem on Feb 15, 2008. Male patient, 82 years of age, was diagnosed with multiple myeloma, neoplasm and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, disease progression, platelet count decreased, prostate cancer, . REVLIMID dosage: 15 MG, 1 IN 1 D, ORAL; 10 MG, 1 IN 1 D, ORAL. Patient died on 01/15/2008.
Seroquel Side Effects Report #5643207-8
SEROQUEL problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 19, 2008. Female patient, 88 years of age, was diagnosed with anxiety and was treated with SEROQUEL. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, platelet count decreased, . SEROQUEL dosage: 50 MG AM AND 200 MG HS. During the same period patient was treated with DEPAKOTE. Patient recovered.
Actiq Side Effects Report #5647572-7
Consumer or non-health professional from UNITED STATES reported ACTIQ problem on Feb 14, 2008. Female patient, 82 years of age, was diagnosed with back pain and was treated with ACTIQ. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, hypotension, screaming, withdrawal syndrome, . ACTIQ dosage: unknown. During the same period patient was treated with FENTANYL TRANSDERMAL SYSTEM, FENTANYL TRANSDERMAL SYSTEM. Patient was hospitalized. Patient recovered.
Infergen Side Effects Report #5649531-7
INFERGEN problem was reported by a Physician from UNITED STATES on Feb 15, 2008. Male patient, weighting 182.0 lb, was diagnosed with hepatitis c and was treated with INFERGEN. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, fatigue, gallbladder operation, platelet count decreased, . INFERGEN dosage: unknown. During the same period patient was treated with RIBAVIRIN, FERROUS SULPHATE, PROCRIT, LANTUS, LISINOPRIL, OXYCODONE. Patient was hospitalized. Patient recovered.
Enbrel Side Effects Report #5598238-3
Physician from BRAZIL reported ENBREL problem on Jan 08, 2008. Female patient, 43 years of age, weighting 127.9 lb, was diagnosed with pustular psoriasis and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, bronchospasm, multi-organ failure, renal failure, respiratory tract infection, sepsis, skin necrosis, stevens-johnson syndrome, . ENBREL dosage: unknown. During the same period patient was treated with FOLIC ACID, DEFLAZACORT, METHOTREXATE. Patient was hospitalized. Patient died on 11/27/2007.
Forteo Side Effects Report #5598566-1
FORTEO problem was reported by a Consumer or non-health professional from GERMANY on Jan 15, 2008. Female patient was diagnosed with osteoporosis and was treated with FORTEO. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, . FORTEO dosage: unknown. During the same period patient was treated with CALCIUM GLUCONATE, VITAMIN D, NEURALGIN. Patient was hospitalized. Patient recovered.
Viani Side Effects Report #5608007-3
Consumer or non-health professional from GERMANY reported VIANI problem on Jan 28, 2008. Female patient, 21 years of age, was treated with VIANI. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, central obesity, cushing's syndrome, depression, erythema, oedema, skin striae, . VIANI dosage: unknown. During the same period patient was treated with CORTISONE, VIANI MITE. Patient recovered.
Aspirin Side Effects Report #5609208-0
ASPIRIN problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 23, 2008. Female patient, 50 years of age, weighting 141.1 lb, was diagnosed with headache and was treated with ASPIRIN. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, contusion, gastric ulcer, loss of consciousness, . ASPIRIN dosage: unknown. Patient was hospitalized. Patient recovered.
Plavix Side Effects Report #5621196-X
Consumer or non-health professional from UNITED STATES reported PLAVIX problem on Dec 15, 2006. Male patient was diagnosed with hypercholesterolaemia, hypertension and was treated with PLAVIX. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, chest discomfort, fatigue, haemorrhage, heart rate irregular, red blood cell count decreased, . PLAVIX dosage: 75 MG QD - ORAL. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5628188-5
REVLIMID problem was reported by a Health Professional from UNITED STATES on Nov 28, 2007. Male patient, 56 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, white blood cell count decreased, . REVLIMID dosage: 25 MG, DAILY X21 DAYS, ORAL. Patient recovered.
Revlimid Side Effects Report #5628425-7
Health Professional from UNITED STATES reported REVLIMID problem on Oct 30, 2007. Male patient, 61 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, . REVLIMID dosage: 25 MG, DAILY FOR 28 DAYS, ORAL ; 10 MG, DAILY FOR 28 DAYS, ORAL. Patient recovered.
Revlimid Side Effects Report #5631095-5
REVLIMID problem was reported by a Physician from UNITED STATES on Dec 19, 2007. Female patient, 83 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, . REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL; 15 MG. Patient recovered.
Revlimid Side Effects Report #5631247-4
Pharmacist from UNITED STATES reported REVLIMID problem on Oct 25, 2007. Male patient, 73 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, . REVLIMID dosage: 10 MG, DAILY X 21 DAYS, ORAL. Patient recovered.
Revlimid Side Effects Report #5631256-5
REVLIMID problem was reported by a Physician from UNITED STATES on Oct 22, 2007. Male patient, 72 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, . REVLIMID dosage: 15 MG, 1 IN 1 D, ORAL. Patient recovered.
Revlimid Side Effects Report #5632497-3
Physician from UNITED STATES reported REVLIMID problem on Dec 04, 2007. Male patient, 77 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, . REVLIMID dosage: 10, 15 MG, QD X 21 DAYS, ORAL. Patient recovered.
Revlimid Side Effects Report #5633589-5
REVLIMID problem was reported by a Health Professional from UNITED STATES on Nov 15, 2007. Female patient, 60 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, . REVLIMID dosage: 15 MG, DAILY, ORAL. Patient recovered.
Revlimid Side Effects Report #5633646-3
Physician from UNITED STATES reported REVLIMID problem on Dec 03, 2007. Male patient, 81 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, . REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL ; 15 MG, 1 IN 1 D, ORAL. Patient recovered.
Revlimid Side Effects Report #5633659-1
REVLIMID problem was reported by a Physician from UNITED STATES on Dec 04, 2007. Female patient, 82 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, . REVLIMID dosage: 25MG TO 15MG, 1 IN 1 D, ORAL ; 10 MG, 1 IN 1 D, ORAL. Patient recovered.
Revlimid Side Effects Report #5633672-4
Health Professional from UNITED STATES reported REVLIMID problem on Dec 04, 2007. Male patient, 75 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, blood creatinine increased, . REVLIMID dosage: 5 MG, 1 IN 1 D, ORAL ; 10 MG, DAILY, ORAL. During the same period patient was treated with EXJADE. Patient recovered.
Revlimid Side Effects Report #5633823-1
REVLIMID problem was reported by a Physician from UNITED STATES on Nov 16, 2007. Female patient, 66 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, . REVLIMID dosage: 25 MG, X21 DAYS / 28 DAYS, ORAL; 15 MG, X21 DAYS / 28 DAYS, ORAL. Patient recovered.
Revlimid Side Effects Report #5634688-4
Health Professional from UNITED STATES reported REVLIMID problem on Dec 12, 2007. Female patient, 69 years of age, was diagnosed with myelofibrosis and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, white blood cell count decreased, . REVLIMID dosage: unknown. Patient recovered.
Revlimid Side Effects Report #5634710-5
REVLIMID problem was reported by a Health Professional from UNITED STATES on Nov 12, 2007. Male patient, 67 years of age, was diagnosed with lymphatic system neoplasm and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, . REVLIMID dosage: 25 MG, DAILY X21 DAYS, ORAL. Patient recovered.
Revlimid Side Effects Report #5634722-1
Health Professional from UNITED STATES reported REVLIMID problem on Nov 12, 2007. Female patient, 65 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, . REVLIMID dosage: 10 MG, DAILY ON DAYS 1-21 AS DIRECTED, ORAL. Patient recovered.
Revlimid Side Effects Report #5634858-5
REVLIMID problem was reported by a Physician from UNITED STATES on Nov 08, 2007. Male patient, 56 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, infection, . REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL ; 5 MG, 1 IN 1 D, ORAL. Patient recovered.
Revlimid Side Effects Report #5635371-1
Consumer or non-health professional from UNITED STATES reported REVLIMID problem on Dec 20, 2007. Male patient, 69 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, . REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL ; 25 MG, 1 IN 1 D, ORAL. Patient recovered.
Revlimid Side Effects Report #5638148-6
REVLIMID problem was reported by a Physician from UNITED STATES on Nov 28, 2007. Male patient, 64 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, . REVLIMID dosage: 25 MG, DAILY X 21 DAYS, ORAL. Patient recovered.
Revlimid Side Effects Report #5638188-7
Health Professional from UNITED STATES reported REVLIMID problem on Nov 29, 2007. Female patient, 68 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, . REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient recovered.
Revlimid Side Effects Report #5638397-7
REVLIMID problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 05, 2007. Female patient was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, haemoglobin decreased, . REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL ; 5MG-10MG, DAILY, ORAL. Patient recovered.
Revlimid Side Effects Report #5638402-8
Consumer or non-health professional from UNITED STATES reported REVLIMID problem on Nov 16, 2007. Male patient, 57 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, bone pain, constipation, dyspnoea, libido decreased, muscle spasms, . REVLIMID dosage: 25 MG, DAILY X 21 DAYS, ORAL. During the same period patient was treated with AREDIA. Patient recovered.
Revlimid Side Effects Report #5638442-9
REVLIMID problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 07, 2007. Male patient, 52 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, . REVLIMID dosage: 15 MG, DAILY X 21 DAYS, ORAL ; 25 MG, DAILY X 21 DAYS, ORAL ; 20 MG, 2 IN 1 D, ORAL. Patient recovered.
Revlimid Side Effects Report #5639329-8
Consumer or non-health professional from UNITED STATES reported REVLIMID problem on Nov 29, 2007. Male patient, 67 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, . REVLIMID dosage: unknown. Patient was hospitalized. Patient recovered.